Concepedia

Rony Dahan

RD

22

Publications

2.4K

Citations

18

H-Index

2004

Active since

Affiliations

Weizmann Institute of Science(Current)

Rockefeller University

Technion – Israel Institute of Technology

Oregon Health & Science University

Tel Aviv University

Rony Dahan is an author at Weizmann Institute of Science specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2004–2025

22

Publications

22

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

Anna‐Maria Georgoudaki, Kajsa E. Prokopec, Vanessa F. Boura et al. · Cell Reports · 2016 · 607 citations · Full text

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon et al. · Immunity · 2017 · 425 citations · Full text

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

Rony Dahan, Emanuela Sega, John Engelhardt et al. · Cancer Cell · 2015 · 389 citations · Full text

, , +9

Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement

Rony Dahan, Bryan C. Barnhart, Fubin Li et al. · Cancer Cell · 2016 · 163 citations · Full text

, , +8

Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity

David A. Knorr, Rony Dahan, Jeffrey V. Ravetch · Proceedings of the National Academy of Sciences · 2018 · 99 citations · Full text

Rows per page

1–5 of 22